Pharmacological targeting of RAS: recent success with direct inhibitors

JP O'Bryan - Pharmacological research, 2019 - Elsevier
RAS has long been viewed as undruggable due to its lack of deep pockets for binding of
small molecule inhibitors. However, recent successes in the development of direct RAS …

[HTML][HTML] Hutchinson-Gilford progeria syndrome

LB Gordon, WT Brown, FS Collins - 2019 - europepmc.org
Hutchinson-Gilford progeria syndrome (HGPS) is characterized by clinical features that
typically develop in childhood and resemble some features of accelerated aging. Children …

Progerin accelerates atherosclerosis by inducing endoplasmic reticulum stress in vascular smooth muscle cells

MR Hamczyk, R Villa‐Bellosta, V Quesada… - EMBO molecular …, 2019 - embopress.org
Hutchinson–Gilford progeria syndrome (HGPS) is a rare genetic disorder caused by
progerin, a mutant lamin A variant. HGPS patients display accelerated aging and die …

Vascular smooth muscle cell‐specific progerin expression in a mouse model of Hutchinson–Gilford progeria syndrome promotes arterial stiffness: Therapeutic effect of …

L Del Campo, A Sánchez‐López, M Salaices… - Aging cell, 2019 - Wiley Online Library
Vascular stiffness is a major cause of cardiovascular disease during normal aging and in
Hutchinson–Gilford progeria syndrome (HGPS), a rare genetic disorder caused by …

[HTML][HTML] Premature aging syndromes: From patients to mechanism

MXR Foo, PF Ong, O Dreesen - Journal of dermatological science, 2019 - Elsevier
Aging is an inevitable consequence of human life resulting in a gradual deterioration of cell,
tissue and organismal function and an increased risk to develop chronic ailments …

ATP-based therapy prevents vascular calcification and extends longevity in a mouse model of Hutchinson–Gilford progeria syndrome

R Villa-Bellosta - Proceedings of the National Academy of …, 2019 - National Acad Sciences
Pyrophosphate deficiency may explain the excessive vascular calcification found in children
with Hutchinson–Gilford progeria syndrome (HGPS) and in a mouse model of this disease …

[HTML][HTML] Hutchinson-Gilford progeria syndrome—current status and prospects for gene therapy treatment

K Piekarowicz, M Machowska, V Dzianisava… - Cells, 2019 - mdpi.com
Hutchinson-Gilford progeria syndrome (HGPS) is one of the most severe disorders among
laminopathies—a heterogeneous group of genetic diseases with a molecular background …

[HTML][HTML] Generation and characterization of a novel knockin minipig model of Hutchinson-Gilford progeria syndrome

B Dorado, GG Pløen, A Barettino, A Macías, P Gonzalo… - Cell discovery, 2019 - nature.com
Hutchinson-Gilford progeria syndrome (HGPS) is an extremely rare genetic disorder for
which no cure exists. The disease is characterized by premature aging and inevitable death …

Transient introduction of human telomerase mRNA improves hallmarks of progeria cells

Y Li, G Zhou, IG Bruno, N Zhang, S Sho, E Tedone… - Aging …, 2019 - Wiley Online Library
Hutchinson–Gilford progeria syndrome (HGPS) is characterized by accelerated senescence
due to a de novo mutation in the LMNA gene. The mutation produces an abnormal lamin A …

Connective tissue and age-related diseases

CA Sarbacher, JT Halper - Biochemistry and Cell Biology of Ageing: Part II …, 2019 - Springer
We begin this chapter by describing normal characteristics of several pertinent connective
tissue components, and some of the basic changes they undergo with ageing. These …